Please Wait
Applying Filters...
menu
    • menu
    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Centocor

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2JANSSEN BIOTECH

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    JANSSEN BIOTECH

    LAZERTINIB MESYLATE

    arrow
    OPRD USA
    Not Confirmed

    JANSSEN BIOTECH

    U.S.A
    arrow
    OPRD USA
    Not Confirmed

    Patent Expiration Date : 2035-10-13

    LAZERTINIB MESYLATE

    US Patent Number : 9593098

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 219008

    Patent Use Code : U-3985

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2035-10-13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    JANSSEN BIOTECH

    LAZERTINIB MESYLATE

    arrow
    OPRD USA
    Not Confirmed

    JANSSEN BIOTECH

    U.S.A
    arrow
    OPRD USA
    Not Confirmed

    Patent Expiration Date : 2035-10-13

    LAZERTINIB MESYLATE

    US Patent Number : 9593098

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 219008

    Patent Use Code : U-3985

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2035-10-13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF